Please assess the completion status of the following clinical trial:

Trial Title: Trial of Liposomal Bupivacaine for TKA

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years and older who are scheduled for a total knee arthroplasty at Northern Light Mercy Hospital~Exclusion Criteria:~* Patients under the age of 18

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Liposomal Bupivacaine (Type: EXPERIMENTAL): Adductor canal block using liposomal bupivacaine and conventional bupivacaine
- Standard of Care (Type: ACTIVE_COMPARATOR): Adductor canal block using conventional bupivacaine

Based on this trial design, predict the completion outcome and termination type (if applicable).